Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases

Bibliographic Details
Main Authors: Na Wang, Jie Liu, Peiran Yang, Dustin Fraidenburg, Haiyang Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1324586/full
_version_ 1797450789773377536
author Na Wang
Jie Liu
Peiran Yang
Dustin Fraidenburg
Haiyang Tang
author_facet Na Wang
Jie Liu
Peiran Yang
Dustin Fraidenburg
Haiyang Tang
author_sort Na Wang
collection DOAJ
first_indexed 2024-03-09T14:45:38Z
format Article
id doaj.art-ab40704ceb424d3cbc2e1be151102c9e
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-09T14:45:38Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-ab40704ceb424d3cbc2e1be151102c9e2023-11-27T06:55:48ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-11-011410.3389/fphar.2023.13245861324586Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseasesNa Wang0Jie Liu1Peiran Yang2Dustin Fraidenburg3Haiyang Tang4Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaKey Laboratory of Arrhythmias of the Ministry of Education of China, Department of Cardiovascular Surgery, Research Center for Translational Medicine, Shanghai Heart Failure Research Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaState Key Laboratory of Respiratory Health and Multimorbidity, Department of Physiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, ChinaDepartment of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, Chinahttps://www.frontiersin.org/articles/10.3389/fphar.2023.1324586/fullrespiratory diseasemetabolismmetabolic pathwayidiopathic pulmonary fibrosisacute lung injurychronic obstructive pulmonary disease
spellingShingle Na Wang
Jie Liu
Peiran Yang
Dustin Fraidenburg
Haiyang Tang
Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
Frontiers in Pharmacology
respiratory disease
metabolism
metabolic pathway
idiopathic pulmonary fibrosis
acute lung injury
chronic obstructive pulmonary disease
title Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
title_full Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
title_fullStr Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
title_full_unstemmed Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
title_short Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
title_sort editorial perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
topic respiratory disease
metabolism
metabolic pathway
idiopathic pulmonary fibrosis
acute lung injury
chronic obstructive pulmonary disease
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1324586/full
work_keys_str_mv AT nawang editorialperspectivesinpharmacologicaltherapytargetingcellularmetabolicpathwaysinrespiratorydiseases
AT jieliu editorialperspectivesinpharmacologicaltherapytargetingcellularmetabolicpathwaysinrespiratorydiseases
AT peiranyang editorialperspectivesinpharmacologicaltherapytargetingcellularmetabolicpathwaysinrespiratorydiseases
AT dustinfraidenburg editorialperspectivesinpharmacologicaltherapytargetingcellularmetabolicpathwaysinrespiratorydiseases
AT haiyangtang editorialperspectivesinpharmacologicaltherapytargetingcellularmetabolicpathwaysinrespiratorydiseases